REVIEWS  PANCREATIC NEOPLASMS 

Minerva Chirurgica 2004 April;59(2):113-22

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

Palliation of pancreatic neoplasms

Thomson B. N. J., Parks R. W.

Pancreatic adenocarcinoma accounts for 80% of pancreatic tumours. The majority are unresectable at diagnosis and only 10% of patients survive to 1 year. Therefore, selection of appropriate palliative procedures for jaundice, gastric outlet obstruction or pain is a vitally important aspect of the management of these patients. Overall survival is equivalent following surgical or non-surgical palliation of biliary obstruction. Operative biliary bypass is a more major intervention but is associated with longer relief of symptoms and fewer readmissions compared to non-operative procedures. Prognostic factors such as histopathology, presence of metastatic disease and C reactive protein levels may allow better prediction of survival, therefore aiding selection of the most appropriate palliative techniques.